Flickering Lights and Sound: A Novel Approach to Slowing Alzheimer’s Disease
Alzheimer’s disease, a devastating neurodegenerative condition, affects millions worldwide. While pharmaceutical research dominates the landscape of potential treatments, a team of researchers at Georgia Institute of Technology and Emory University is pioneering a different approach: using flickering lights and sound to potentially slow cognitive decline. This non-invasive method offers a promising alternative or complement to traditional drug therapies.
Understanding the New Approach
Led by biomedical engineer Annabelle Singer, PhD, associate professor in the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University [1], the research focuses on understanding how neural activity patterns underpin memory and how these patterns are disrupted in Alzheimer’s disease. Instead of targeting molecular processes like protein accumulation, Singer’s team investigates the electrical activity of neurons.
The intervention involves a device resembling ski goggles and headphones. The goggles emit flickering lights at approximately five times the rate of a typical strobe light, while the headphones deliver a fast-clicking, beeping sound. This stimulation, applied for about one hour daily, aims to influence the neural activity involved in memory and potentially slow the progression of the disease. [3]
Promising Results from Early Studies
Preclinical studies and a feasibility study have shown encouraging results. Daily exposure to 40 Hz intermittent light and sound for one hour has demonstrated the potential to slow cognitive decline and reduce volume loss in brain regions crucial for memory. [3] Researchers emphasize that the goal isn’t to recover lost memory but to slow down the ongoing degradation of cognitive function. [3]
A previous study, conducted in collaboration with Emory University’s Cognitive Neurology Program, evaluated 10 patients with mild cognitive impairment over eight weeks. Analysis of cerebrospinal fluid and electroencephalograms revealed changes in electrical connectivity patterns following the stimulation. [3]
How Does It Work?
Singer’s approach stems from a belief that existing Alzheimer’s drugs carry potential side effects without consistently demonstrating sufficient efficacy. She questioned whether an alternative method could be developed by focusing on the fundamental electrical behavior of neurons. [3]
The 40 Hz stimulation is believed to trigger a significant release of signaling substances called cytokines, potentially influencing brain health. [3] The mechanism by which flashing lights may even reduce subclinical seizure activity is still under investigation. [3]
Current Clinical Trials
A Phase 3, double-blind clinical trial, involving nearly 700 patients at 70 centers across the United States, is currently underway. The study is coordinated by Cognito Therapeutics, a company specializing in portable medical devices. [3] Completion is anticipated by the end of 2026. [3]
The Broader Context of Alzheimer’s Treatment
Alzheimer’s disease affects over seven million people aged 65 and older in the United States, with projections reaching 13.8 million by 2060 without significant medical advancements. [3] Worldwide, approximately 57 million people live with dementia, with Alzheimer’s being the most common form, according to the World Health Organization. [3]
The FDA has recently accelerated the approval of drugs like lecanemab and donanemab, which have shown modest reductions in cognitive decline in clinical trials (27% and 35% respectively). [3] However, these therapies can cause severe side effects and are expensive, costing around $30,000 per year. [3]
Singer’s research offers a potentially non-invasive, low-risk and more accessible intervention. The results of the Phase 3 clinical trial will be crucial in determining whether 40 Hz light and sound stimulation can significantly slow cognitive decline in Alzheimer’s patients.